|
|
|
Volumn 23, Issue 4 SUPPL. 8, 1996, Pages 90-99
|
|
Future development of amifostine in cancer treatment
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
2 (3 AMINOPROPYLAMINO)ETHANETHIOL;
AMIFOSTINE;
ANTINEOPLASTIC AGENT;
BUSULFAN;
CARBOPLATIN;
CISPLATIN;
CYCLOPHOSPHAMIDE;
DEXAMETHASONE;
DOXORUBICIN;
ETOPOSIDE;
FLUOROURACIL;
GRANULOCYTE COLONY STIMULATING FACTOR;
IFOSFAMIDE;
MELPHALAN;
METHOTREXATE;
ONDANSETRON;
PACLITAXEL;
RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;
VINBLASTINE;
BLADDER CANCER;
BREAST CANCER;
CANCER CHEMOTHERAPY;
CARDIOTOXICITY;
CELL PROTECTION;
CLINICAL PROTOCOL;
CLINICAL TRIAL;
CONFERENCE PAPER;
HEAD AND NECK CANCER;
HUMAN;
HYPOTENSION;
INTRAARTERIAL DRUG ADMINISTRATION;
INTRACEREBROVENTRICULAR DRUG ADMINISTRATION;
INTRATHECAL DRUG ADMINISTRATION;
INTRAVENOUS DRUG ADMINISTRATION;
LUNG CANCER;
MELANOMA;
MUTAGENICITY;
NEPHROTOXICITY;
NEUROTOXICITY;
NEUTROPENIA;
NONHODGKIN LYMPHOMA;
NONHUMAN;
OVARY CANCER;
PHASE 1 CLINICAL TRIAL;
PHASE 2 CLINICAL TRIAL;
PHASE 3 CLINICAL TRIAL;
PRIORITY JOURNAL;
RECTUM CANCER;
THROMBOCYTE TRANSFUSION;
THROMBOCYTOPENIA;
UTERINE CERVIX CANCER;
VOMITING;
ADULT;
AMIFOSTINE;
ANTINEOPLASTIC AGENTS;
CHILD;
CLINICAL TRIALS, PHASE II;
CLINICAL TRIALS, PHASE III;
HUMANS;
NEOPLASMS;
|
|
EID: 0029761498
PISSN: 00937754
EISSN: None
Source Type: Journal
DOI: None Document Type: Conference Paper |
|
Times cited : (23)
|
|
References (0)
|
